F. Cicora,P. Stringa,D. Guerrieri,D. Vasquez,F. Toniolo,J. Roberti and C. Raimondi. Evaluation of histological damage of solid organs after donor preconditioning with thymoglobulin in an experimental rat model. Transpl Immunol. 2013;28(4):10.1016/j.trim.2013.04.002.
F. Augustovski,S. García Martí and A. Pichon-Riviere. Consolidated Health Economic Evaluation Reporting Standards: Spanish Version of the CHEERS Checklist. Value Health Reg Issues. 2013;2(3):10.1016/j.vhri.2013.10.004.
SG Marti,A. Alcaraz,P. Valanzasca,OU Garay,M. McMullen, LR Ares, CA Obando and J. Caporale. COST-EFFECTIVENESS OF TELAPREVIR IN GENOTYPE 1 CHRONIC HEPATITIS-C VIRUS INFECTION IN VENEZUELA. Value in Health. 2013;16(7).
SG Marti,A. Alcaraz,P. Valanzasca,UG Ulysses,M. McMullen,L.R. Ares,I. Peirano, DO Reisberg, AS Ried, J. Poniachik, JRB Barril and J. Caporale. COST-EFFECTIVENESS OF TELAPREVIR IN GENOTYPE 1 CHRONIC HEPATITIS C VIRUS (HCV) INFECTION IN CHILE. Value in Health. 2013;16(7).
SG Marti,A. Alcaraz,P. Valanzasca,OU Garay,M. McMullen,L.R. Ares,V. Idrovo, JP Ortiz, M. Tapias,J. Obregon, JG Ariza and J. Caporale. COST-EFFECTIVENESS OF TELAPREVIR IN GENOTYPE 1 CHRONIC HEPATITIS C VIRUS (HCV) INFECTION IN COLOMBIA. Value in Health. 2013;16(7).
SG Marti,A. Alcaraz,P. Valanzasca,UG Ulysses,M. McMullen,L.R. Ares,I. Peirano,F. Bessone,H. Fainboim,A. Gadano,O. Galdame,C. Vujacich and J. Caporale. COST-EFFECTIVENESS OF TELAPREVIR IN GENOTYPE 1 CHRONIC HEPATITIS C VIRUS (HCV) INFECTION IN ARGENTINA. Value in Health. 2013;16(7).
D. Husereau,M. Drummond,S. Petrou,C. Carswell,D. Moher,D. Greenberg,F. Augustovski, AH Briggs, J. Mauskopf,E. Loder and IHEE Publica. Consolidated Health Economic Evaluation Reporting Standards (CHEERS)-Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force. Value in Health. 2013;16(2):10.1016/j.jval.2013.02.002.
MD Defagó,D. Gu,JE Hixson,LC Shimmin,TK Rice,CC Gu,CE Jaquish,DP Liu,J. He and TN Kelly. Common genetic variants in the endothelial system predict blood pressure response to sodium intake: the GenSalt study. Am J Hypertens. 2013;26(5):10.1093/ajh/hps099.
F. Cicora,F. Mos,M. Paz and J. Roberti. Clinical experience with thymoglobulin and antithymocyte globulin-Fresenius as induction therapy in renal transplant patients: a retrospective study. Exp Clin Transplant. 2013;11(5):10.6002/ect.2013.0027.
A. Pichon-Riviere,J. Caporale,A. Alcaraz,A. Bardach,K. Klein, LR Ares and F. Augustovski. CALIBRATION OF A COST-EFFECTIVENESS MODEL TO EVALUATE THE INCORPORATION OF A QUADRIVALENT HPV TYPES 6, 11, 16, 18 VACCINE IN ARGENTINA: DISEASE BURDEN COMPONENT. Value in Health. 2013;16(7):10.1016/j.jval.2013.08.2126.
